Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway

Alopecia areata (AA) is an immune-mediated condition, clinically manifesting as non-cicatricial patches of alopecia. It is often a self-limiting condition; however, regrowth of hair can take a long period of time, resulting in significant psychological comorbidity. With the recent advances in pathom...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kabir Sardana (Auteur), Savitha Bathula (Auteur), Ananta Khurana (Auteur)
Format: Livre
Publié: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible